NIRAMAI HEALTH ANALYTIX UK LTD
COMPANY REGISTRATION NUMBER: 13877488
Unaudited Financial Statements
31 March 2023
NIRAMAI HEALTH ANALYTIX UK LTD
Financial Statements
Year ended 31 March 2023
Contents
Officers and Professional Advisors
1
Directors Report
2
Statement of Income and Retained Earnings
3
Statement of Financial Position
4
Notes to the financial statements
5
NIRAMAI HEALTH ANALYTIX UK LTD
Officers and Professional Advisors
Directors
Dr Geetha Manjunath
K Siva Teja
Registered Office
6th Floor
       9 Appold Street
      London
        United Kingdom
EC2A 2AP
NIRAMAI HEALTH ANALYTIX UK LTD
Directors' Report
Year ended 31 March 2023
The directors present this report and the unaudited financial statements of the company for the period ended 31 March 2023.
Principal Activities
The company was incorporated on 28 January 2022 and its principal activities was that of providing a breast cancer detection solution.
Directors
The directors' who served the company during the period are as follows:
1.
Dr Geetha Manjunath (appointed 28 January 2022)
2.
K Siva Teja (appointed 28 January 2022)
Small Company Provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies' exemption.
This report was approved by the board of directors on
24 September 2023
24 September 2023
and signed on behalf of the board by:
Dr Geetha Manjunath
Director
Page 4
NIRAMAI HEALTH ANALYTIX UK LTD
Statement of Income and Retained Earnings
Period ended 31 March 2023
Note
March 2023
£
Administrative expenses
630
Loss Before Taxation
(630)
Taxation
-
Losses for the Financial Year and Total Comprehensive loss
(630)
Page 5
NIRAMAI HEALTH ANALYTIX UK LTD
Statement of Financial Position
31 March 2023
Company registration number: 13877488
31 March 2023
Note
£
CURRENT LIABILITIES
Creditors
6
530
CAPITAL AND RESERVES
Called up share capital
7
100
Profit and loss reserves
(630)
530
The financial statements have been prepared and delivered in accordance with the provisions applicable to the companies subject to the small companies regime.
For the period ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements were approved by the board of directors and authorized for issue on 24 September 2023, and are signed on behalf of the board by:
Dr Geetha Manjunath
Director
Page 6
NIRAMAI HEALTH ANALYTIX UK LTD
Notes to the Financial Statements
31 March 2023
1.
General Information
The Company is a private company limited by shares, registered in England and Wales. The address of the registered office is 6th Floor, 9 Appold Street, London, United Kingdom, EC2A 2AP.
2.
Comparatives
This being the first year of operations, no comparative numbers are presented.
3.
Accounting policies
Accounting convention
These financial statements have been prepared in accordance with Section 1A of FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The statements are prepared in sterling, which is the functional currency of the entity. Monetary amounts in these financial statements are rounded to the nearest pound.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
Financial instruments
The Company only has basic financial instruments measured at amortised cost, with no financial instruments classified as ‘other' or basic instruments measured at fair value.
Page 7
NIRAMAI HEALTH ANALYTIX UK LTD
Notes to the Financial Statements (Continued)
31 March 2023
4.
Judgements and Key Sources of Estimation Uncertainty:
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Accounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. The directors are of the opinion that there are no estimates or assumptions that have a significant risk of causing a material adjustment to the carrying value of assets and liabilities within the next financial year.
5.
Employee Numbers:
There are no employees in the company during the period of operations.
6.
Creditors: amounts falling due within one year
31 March 2023
£
Amounts due from group undertakings
530
7.
Called share capital
31 March 2023
£
100 Ordinary shares of £1 each
100
8.
Parent company
The Company is a subsidiary of NIRAMAI Health Analytix Private Limited, a company registered in India. The registered office address is Flat A7-506, Elita Promenade, J P Nagar 7th Phase, Bangalore, Karnataka, 560078, India.
─-
Page 8
falseCCH SoftwareiXBRL Review & Tag 2022.22023-03-312022-01-280Not audited2023-09-28Not audited138774882022-01-282023-03-31138774882023-03-3113877488bus:Director12022-01-282023-03-3113877488bus:Director22022-01-282023-03-3113877488bus:FRS1022022-01-282023-03-3113877488bus:PrivateLimitedCompanyLtd2022-01-282023-03-3113877488bus:AuditExempt-NoAccountantsReport2022-01-282023-03-3113877488bus:FullAccounts2022-01-282023-03-31xbrli:purexbrli:sharesiso4217:GBP